Android Apple

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M | TechCrunch

By TechCrunch   |   4 months ago
Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M | TechCrunch

UK-based startup Healx, using AI for drug discovery in rare diseases, raised $47 million in Series C funding led by Atomico and R42. The company obtained regulatory approval for Phase 2 clinical trials in the US.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.